Between Ro and PlushCare, you're comparing two solid options for weight loss and hair loss, where Ro pushes you toward actual Wegovy with insurance navigation and a $145/mo membership after your first month, while PlushCare leans on compounded semaglutide and board-certified doctors who can order labs and get you a prescription within a week. Both are available in all 50 states plus DC.
Pick Ro if
You want Wegovy specifically, not a compounded substitute, and you're fine paying for the membership structure that includes coaching and check-ins.
Pick PlushCare if
You'd rather see a board-certified doctor, keep your insurance copay in play, and pick up your prescription at a pharmacy or get it delivered.
Choose Ro if you want the real-name medication, free unlimited doctor follow-ups, and a structured monthly program with tracking built in. Choose PlushCare if you want flexibility on payment, a doctor who can order labs on the spot, and access to a wider drug list like dutasteride or avanafil. Ro holds a slightly higher rating at 8.9 across 32,100 reviews versus PlushCare's 8.6 across 19,200. Your call.
Quick Answer
Best overallRo
Most reviewedRo
Ro is our overall pick for weight loss, based on ratings, reviews, and feature coverage.
Provider Overview
8.8(3,200 reviews on Trustpilot)
Ro (formerly Roman) is a full-service telehealth platform offering treatments for ED, hair loss, weight loss, and more. Known for its strong weight loss program with personalized coaching.
PlushCare is a full-service telehealth platform offering virtual urgent care, primary care, and treatment for various conditions including ED, weight loss, and women's health.
Adults with a BMI over 27 who want real Wegovy, not a compounded version.
You prefer having insurance paperwork handled without doing it yourself.
You want coaching and check-ins included, not just a prescription and a portal.
Not for
Not for you if you are pregnant or actively trying to become pregnant.
Not the right fit if your BMI is under 27 and you lack a weight-related condition.
Not for you if you have a history of an eating disorder like anorexia or bulimia.
PlushCare
This is for
Adults with a BMI over 27 who want GLP-1 medication without a long wait.
You have insurance or can pay cash and want ongoing doctor monitoring included.
You need compounded semaglutide while name-brand Ozempic or Wegovy stays hard to find.
Not for
You are pregnant, breastfeeding, or planning to become pregnant soon.
You have a history of an eating disorder requiring specialized in-person treatment.
Your BMI is under 27 with no weight-related health conditions making you eligible for GLP-1s.
About This Comparison
Our Editorial Standards
This ro vs plushcare provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Independent ResearchUnbiased provider comparisons
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated March 18, 2026
Licensed Providers OnlyAll listed services are US-licensed
Ro vs PlushCare: Complete Comparison Guide
Written by Eric GoldEditor-in-Chief
14 min readUpdated March 18, 2026
complete analysis comparing Ro and PlushCare across pricing, features, treatments, and user experience.
Platform Overview
PlushCare operates complete primary care telemedicine platform serving both men and women across diverse medical conditions including hair loss, chronic disease management, mental health, acute illness, and preventive care. The platform employs board-certified family medicine and internal medicine physicians providing synchronous video consultations (15-minute appointments) for diagnostic evaluation and treatment planning. Hair loss treatment represents one clinical offering among extensive primary care services, with providers prescribing finasteride, minoxidil, spironolactone, and other FDA-approved medications as clinically appropriate. PlushCare accepts most major insurance plans charging visit fees ($129-199 without insurance, $10-50 copays with coverage), positioning as virtual primary care clinic providing complete medical evaluation across full health spectrum. Source: PlushCare platform analysis 2025
Ro operates multi-category men's and women's health telemedicine platform offering hair loss, weight loss, erectile dysfunction, sexual wellness, and skincare services. The platform prescribes FDA-approved pharmaceutical treatments including finasteride, minoxidil, and spironolactone through asynchronous consultations with physicians and nurse practitioners at $20-90 monthly depending on medication selection. Ro positions as complete digital health service with competitive pharmaceutical pricing, evidence-based treatment approaches, and efficient asynchronous consultation model emphasizing convenience and affordability. The multi-category platform serves both men and women across diverse health concerns, providing nationwide provider network accessibility through streamlined messaging-based consultations. Source: Ro platform analysis 2025
This comparison examines primary care video consultation platform (PlushCare) versus efficient asynchronous pharmaceutical service (Ro) for hair loss treatment. The platforms differ in consultation models (synchronous video vs asynchronous messaging), provider types (physicians only vs physician/NP mix), pricing structures (per-visit fees vs subscription), insurance integration (extensive vs limited), service positioning (primary care clinic vs specialized health categories), and cost profiles (insurance-dependent vs fixed pricing). Selection depends on insurance coverage, consultation format preferences, value placed on real-time physician interaction, diagnostic breadth needs, and budget considerations.
Consultation Models: Synchronous Video vs Asynchronous Messaging
PlushCare employs synchronous video consultation model requiring scheduled appointments (15-minute slots) with board-certified physicians. Patients book time-specific video visits where providers conduct real-time clinical interviews, visual assessments, and complete medical discussions before prescribing treatments. The synchronous format enables bidirectional conversation, immediate clarification questions, and thorough medical evaluation beyond photograph review. Physicians can assess patient concerns holistically, conduct differential diagnosis during conversation, coordinate hair loss treatment with existing medical conditions, and provide personalized recommendations through face-to-face virtual interaction. This consultation depth requires appointment scheduling and dedicated visit time but enables complete primary care evaluation across full diagnostic spectrum. Source: Synchronous telemedicine effectiveness
Ro utilizes asynchronous consultation model where patients complete questionnaires, upload scalp photographs, and submit treatment requests without scheduled appointments. Physicians and nurse practitioners review submitted information within 24-48 hours, prescribing medications if clinically appropriate or requesting additional information if contraindications exist. The asynchronous approach eliminates appointment scheduling, wait times, and real-time conversation requirements—patients receive prescriptions via platform messaging without video interaction. This model prioritizes convenience and cost efficiency for straightforward androgenetic alopecia cases where photograph-based assessment and medical history screening sufficiently determine treatment appropriateness. Quarterly touchpoints occur through messaging rather than scheduled video appointments. Source: Asynchronous telemedicine models
The consultation format distinction significantly impacts convenience, clinical depth, and cost trade-offs. PlushCare's synchronous video model provides complete real-time evaluation, diagnostic conversation, and immediate physician interaction but requires appointment coordination and dedicated time commitment. Ro's asynchronous model maximizes convenience—patients submit information anytime without scheduling constraints—and enables budget pricing through consultation efficiency, but limits provider interaction to one-way review rather than bidirectional discussion. Patients with straightforward male or female pattern baldness seeking prescription access often find Ro's asynchronous model sufficient and convenient; those desiring thorough medical evaluation, diagnostic investigation, or real-time physician consultation benefit from PlushCare's synchronous format despite appointment requirements. Source: Telemedicine consultation format comparison
Insurance Integration and Cost Structures
PlushCare maintains extensive insurance integration accepting most major plans including Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, Medicare, and others. Patients with insurance typically pay standard specialist copays ($10-50 depending on plan benefits) rather than full visit fees, substantially reducing out-of-pocket costs compared to uninsured rates. The platform processes insurance claims directly, enabling patients to utilize existing health benefits for telemedicine visits. Total annual costs vary dramatically by insurance status: well-insured patients pay $40-200 annually for quarterly visits at copay rates ($10-50 per visit) plus pharmacy-covered medications, while uninsured patients face $400-800+ annually for consultations ($129-199 initial, $99-149 follow-ups) before medication expenses. Insurance coverage represents critical cost variable determining PlushCare affordability. Source: PlushCare insurance acceptance 2025
Ro operates primarily self-pay subscription model with transparent pricing: $20-90 monthly ($240-1,080 annually) for hair loss prescriptions including medications and provider consultations. The platform accepts some insurance for prescription medications with coverage varying by plan formularies, potentially reducing medication costs below advertised subscription prices, though consultation fees typically fall outside standard insurance coverage. Most patients pay advertised subscription rates regardless of insurance status, creating predictable out-of-pocket expenses without significant insurance impact. The fixed pricing model eliminates insurance complexity but offers limited cost reduction opportunities through health benefits coverage. Annual costs remain consistent at $240-1,080 depending on medication selection for most patients. Source: Ro pricing structure 2025
Insurance represents dramatic differentiator affecting relative costs: PlushCare costs $40-200 annually for well-insured patients (low copays) or $400-800+ for uninsured patients, while Ro costs $240-1,080 annually regardless of insurance status. Patients with complete insurance providing low specialist copays and prescription drug coverage often pay less through PlushCare ($40-200 plus insured pharmacy costs) than Ro's fixed subscription pricing ($240-1,080). Uninsured patients or those with high-deductible plans may find Ro more affordable or comparable—fixed subscription pricing ($240-1,080) versus PlushCare uninsured rates ($400-800+ before medications). The insurance variable critically determines which platform offers better value, with well-insured populations strongly favoring PlushCare's integrated model while uninsured patients benefit from Ro's predictable subscription approach. Source: Insurance impact on telehealth costs
Clinical Scope and Diagnostic Capabilities
PlushCare provides complete primary care services across full medical spectrum—hair loss treatment exists among chronic disease management, mental health services, acute illness care, preventive medicine, and diagnostic evaluation. Board-certified primary care physicians bring extensive medical training enabling identification of underlying causes beyond androgenetic alopecia: thyroid disorders, nutritional deficiencies, hormonal imbalances, autoimmune conditions, or medication side effects causing hair loss. Physicians can order laboratory testing, conduct differential diagnosis across medical specialties, coordinate with existing health conditions and medications, and provide holistic healthcare beyond isolated hair loss prescription writing. The complete primary care scope enables thorough medical evaluation for atypical presentations or suspected systemic causes requiring investigation beyond routine pattern baldness assessment. Source: Primary care scope in telemedicine
Ro focuses specifically on defined health categories—hair loss, weight loss, erectile dysfunction, sexual wellness, skincare—rather than complete primary care. The platform prescribes FDA-approved medications for straightforward presentations within service categories but operates with narrower diagnostic scope compared to full-spectrum primary care. Providers assess standard androgenetic alopecia patterns through photograph review and medical history but lack complete primary care breadth for investigating complex underlying causes, ordering extensive laboratory workups, or managing multiple comorbid conditions affecting treatment selection. The focused model efficiently serves patients with straightforward hair loss seeking pharmaceutical treatment without requiring complete medical evaluation, though it provides limited diagnostic investigation capabilities for atypical presentations or suspected systemic causes. Source: Category-focused telemedicine models
The clinical scope distinction affects diagnostic capabilities and appropriate patient selection: PlushCare's primary care physicians provide complete medical evaluation identifying underlying causes, coordinating with complex medical histories, and conducting thorough differential diagnosis beyond routine pattern baldness assessment. Ro's category-focused model efficiently prescribes FDA-approved medications for straightforward androgenetic alopecia but provides limited diagnostic breadth for complex presentations. Patients with atypical hair loss patterns, sudden onset, suspected systemic causes, or complex medical histories benefit from PlushCare's complete primary care capabilities. Those with typical male or female pattern baldness seeking efficient pharmaceutical access find Ro's focused model sufficient without requiring extensive diagnostic investigation. Source: Diagnostic scope in telemedicine
Provider Credentials and Medical Training
PlushCare exclusively employs board-certified family medicine and internal medicine physicians (no nurse practitioners in most states) for all consultations, emphasizing physician-led primary care as service foundation. These physicians complete complete medical residency training across full patient lifespan and condition spectrum, bringing extensive diagnostic education and clinical experience beyond hair loss specialty. While individual physicians may see fewer hair loss cases than platforms focused narrowly on dermatology, they possess broad diagnostic capabilities to identify uncommon causes, complex presentations, and systemic conditions manifesting as hair loss. The complete medical training enables holistic patient assessment, laboratory interpretation, specialist referrals, and management of multiple comorbid conditions affecting treatment safety and selection. Source: Primary care physician training
Ro employs both physicians and nurse practitioners for hair loss consultations, with credential mix varying by state regulatory requirements and case complexity. Nurse practitioners provide appropriate clinical oversight for routine hair loss prescriptions within scope of practice for standard androgenetic alopecia treatment. Physicians handle complex cases requiring broader diagnostic consideration. The provider mix enables cost-efficient consultation model while maintaining clinical appropriateness—NPs manage straightforward cases while physicians address complex presentations. Ro providers practice across multiple health categories (hair loss, weight loss, ED) rather than specializing exclusively in single domain, bringing category-specific knowledge rather than complete primary care training across full medical spectrum. Source: Nurse practitioner scope in telemedicine
The provider credential distinction reflects platform positioning: PlushCare's board-certified primary care physicians bring complete medical training with broad diagnostic capabilities across full health spectrum, while Ro's physician/NP mix enables cost-efficient consultations appropriate for routine prescriptions within defined health categories. For straightforward androgenetic alopecia, clinical outcomes likely differ minimally between competent providers regardless of credential type—both appropriately prescribe finasteride and minoxidil for typical presentations. For complex cases requiring complete medical evaluation, differential diagnosis, or coordination with multiple health conditions, PlushCare's primary care physician training provides diagnostic depth advantages. The credential difference matters most for patients with complex medical histories, atypical presentations, or those valuing physician-only complete primary care evaluation. Source: Provider credentials and clinical outcomes
Pricing Models and Long-Term Cost Implications
PlushCare operates per-visit fee model charging $129-199 for new patient consultations and $99-149 for follow-up appointments without insurance. With insurance, patients typically pay standard copays ($10-50) rather than full fees. The fee-per-visit structure means hair loss consultations require payment for each appointment—initial evaluation, follow-up visits, prescription renewals beyond automated refills. Medication costs additional through patient's pharmacy or mail-order service. Long-term costs depend critically on insurance: well-insured patients with low copays ($10-20 per quarterly visit) pay $40-80 annually for consultations plus pharmacy-covered medications (generic finasteride $10-30 monthly, minoxidil $15-40 monthly with drug coverage), totaling potentially $200-500 annually all-inclusive. Uninsured patients face $400-800+ annually for quarterly consultations plus separate medication expenses. Source: PlushCare pricing structure 2025
Ro charges subscription pricing bundling medications and consultations: $20-90 monthly ($240-1,080 annually) depending on medication selection—minoxidil alone $20-30 monthly, finasteride alone $35-50 monthly, combination therapy $60-90 monthly. The subscription model creates predictable monthly expenses with all-inclusive pricing (medications, provider oversight, quarterly reviews). Long-term costs remain consistent at advertised rates for most patients regardless of insurance status, creating budget predictability but limited insurance benefit potential. Annual costs of $240-1,080 provide transparent pricing without hidden consultation fees or pharmacy charges, though subscription approach offers minimal cost reduction through insurance coverage beyond potential medication formulary benefits. Source: Ro pricing structure 2025
Long-term cost comparison reveals insurance coverage as critical variable: well-insured PlushCare patients often pay less ($200-500 annually total including medications with insurance) than Ro's subscription pricing ($240-1,080), while uninsured patients face comparable or higher PlushCare costs ($600-1,200+ annually) versus Ro's predictable subscription model. Over typical 5-year treatment commitment, insurance differential compounds substantially—well-insured patients save potentially $1,500-3,000 through PlushCare versus Ro, while uninsured patients may save $1,000-2,000+ through Ro versus uninsured PlushCare rates. Insurance status determines optimal financial choice: complete coverage strongly favors PlushCare, while limited/no insurance favors Ro's predictable subscription approach. Source: Long-term telehealth cost analysis
How We Tested Ro vs PlushCare
Methodology & Clinical Evidence
This comparison synthesizes publicly available information about PlushCare and Ro service models, consultation formats, pricing structures, provider credentials, insurance acceptance, and clinical scope as of January 2026. Analysis incorporates platform marketing materials, terms of service, provider credential disclosures, pricing schedules, insurance partnership information, and service positioning statements from official websites. Clinical effectiveness assessments reference FDA approval data for finasteride, minoxidil, and spironolactone in androgenetic alopecia treatment, with efficacy expectations identical across platforms given both prescribe same pharmaceutical interventions. Consultation model comparisons incorporate telemedicine literature evaluating synchronous versus asynchronous care formats, diagnostic capabilities research, and patient satisfaction studies. Cost analyses reflect advertised pricing and typical insurance copay ranges without accounting for individual plan variables, promotional discounts, or geographic pricing variations. Medical supervision considerations incorporate primary care and telemedicine literature on clinical evaluation standards. This analysis does not constitute medical advice; patients should consult licensed healthcare providers to determine appropriate hair loss treatment based on individual medical history, underlying conditions, and diagnostic evaluation requirements.
Final Verdict: Ro vs PlushCare
Final Verdict: Insurance-Integrated Primary Care vs Efficient Subscription Platform
PlushCare and Ro represent different telemedicine models—complete primary care with video consultations versus efficient category-focused platform with asynchronous messaging. Optimal selection depends critically on insurance coverage (dramatic cost impact), consultation format preferences, diagnostic breadth needs, and value placed on real-time physician interaction versus convenient messaging-based care.
PlushCare excels for patients with complete health insurance, providing dramatically better value through low copays ($40-200 annually) versus Ro's fixed subscription pricing ($240-1,080)—savings of potentially $1,500-3,000 over 5 years. Board-certified primary care physicians bring complete medical training enabling identification of underlying causes, thorough differential diagnosis, and holistic healthcare coordination beyond isolated hair loss treatment. Synchronous video consultations provide real-time diagnostic conversation and complete medical evaluation. The insurance-integrated model makes PlushCare optimal choice for well-insured patients seeking thorough medical assessment with financial accessibility through health benefits.
Ro excels for uninsured patients and those prioritizing maximum convenience through asynchronous consultations without appointment scheduling. Predictable subscription pricing ($240-1,080 annually) creates transparent costs substantially lower than PlushCare uninsured rates ($600-1,200+). Efficient messaging-based consultations eliminate appointment coordination, enabling patients to submit information anytime receiving provider review within 24-48 hours. The streamlined model suits straightforward androgenetic alopecia cases seeking convenient pharmaceutical access without complete primary care evaluation needs.
The fundamental selection factors involve insurance coverage (determines dramatic cost differential), consultation format preferences (real-time video vs convenient messaging), and diagnostic breadth requirements (complete primary care vs focused pharmaceutical prescribing). Clinical outcomes for straightforward pattern baldness likely differ minimally—both prescribe identical FDA-approved medications with appropriate medical oversight—making insurance status and consultation format preference primary differentiators rather than treatment efficacy itself.
Choose PlushCare if:
You have complete health insurance providing low specialist copays (saves $1,500-3,000 over 5 years)
You prioritize complete primary care evaluation and diagnostic investigation
You value synchronous video consultations with board-certified primary care physicians
You want holistic healthcare coordination across multiple health conditions
You desire thorough medical assessment for atypical presentations or underlying cause investigation
You accept appointment scheduling requirements for real-time physician consultation depth
You seek insurance-integrated care utilizing existing health benefits for maximum affordability
Choose Ro if:
You lack health insurance or have high-deductible plans (Ro costs less without insurance benefits)
You prioritize maximum convenience through asynchronous consultations without appointments
You have straightforward pattern baldness without complex diagnostic needs
You value predictable subscription pricing ($240-1,080/year) with transparent costs
You want efficient pharmaceutical access without complete primary care evaluation
You prefer messaging-based consultations completed on your timeline without scheduling
You seek budget-efficient treatment when insurance benefits don't significantly reduce costs
Bottom line: PlushCare and Ro serve different patient needs through fundamentally different models—insurance-integrated complete primary care versus efficient subscription pharmaceutical access. Insurance coverage represents critical selection factor: well-insured patients save dramatically through PlushCare ($200-500 annually vs $240-1,080 at Ro), while uninsured patients benefit from Ro's predictable subscription approach ($240-1,080 vs $600-1,200+ at PlushCare). Both prescribe identical FDA-approved medications—selection hinges on insurance status (mandatory consideration), consultation format preferences (video vs messaging), diagnostic breadth needs (complete vs focused), and value placed on primary care relationship versus efficient pharmaceutical prescribing. Most patients optimally choose based on insurance coverage first, then consider consultation format and diagnostic needs as secondary factors.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
PlushCareComprehensive primary care telehealth platform
RoComprehensive telehealth platform for men's and women's health
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.
Medical Disclaimer: The information on this page is for educational purposes only and is not medical advice. Always consult with a licensed healthcare provider before starting any treatment. Read our full medical disclaimer.
